Beta Lifescience products

Antibodies

Beta Lifescience - Anti-2019-nCoV NP mAb (IgG&IgM Positive Control)

The Anti SARS-COV2 / 2019-nCoV NP mAb (IgG&IgM Positive Control) product contains two isotype antibody clone Human IgG and IgM, which can recognizes2019-nCoV Nucleocapsid Protein.

Beta Lifescience - Mouse Anti 2019-nCoV Spike RBD Monoclonal Antibody

Anti-Spike RBD Protein of SARS-CoV-2 (2019-nCoV/Wuhan), Mouse Monoclonal Antibody

Beta Lifescience - Rabbit Anti 2019-nCoV Nucleoprotein / NP Polyclonal Antibody

2019-nCoV (COVID-19) Nucleocapsid Antibody, Rabbit Polyclonal Antibody, Antigen Affinity Purified .Produced in rabbits immunized with purified, recombinant SARS-CoV-2 / 2019-nCoV Nucleocapsid Protein (YP_009724397.2(335Gly/Ala); Met1-Ala419). The specific IgG was purified by SARS-CoV-2 / 2019-nCoV Nucleocapsid affinity chromatography.

Tool Enzymes & Other Reagents

Beta Lifescience - RNase Inhibitor, Mammalian

RNase Inhibitor, Mammalian specifically inhibits RNases A, B and C. It inhibits RNases by binding noncovalently in a 1:1 ratio with high affinity. It is not effective against RNase 1, RNase T1, S1 Nuclease, RNase H or RNase from Aspergillus. In addition, no inhibition of polymerase activity is observed when RNase Inhibitor is used with Taq DNA Polymerase, AMV or M-MuLV Reverse Transcriptases, or Phage RNA Polymerases (SP6, T7, or T3). The 50 kDa protein inhibits RNases by binding noncovalently in a 1:1 ratio with an association constant greater than 10^14.